vimarsana.com
Home
Live Updates
BioNTech SE: Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA : vimarsana.com
BioNTech SE: Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA
With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy of two 3 µg doses as part of a three-dose primary
Related Keywords
Germany
,
Finland
,
United States
,
Canada
,
Poland
,
United Kingdom
,
Spain
,
American
,
Sylke Maas
,
Albert Bourla
,
Ugur Sahin
,
Fosun Pharma
,
American Academy Of Pediatrics
,
Centers For Disease
,
Linkedin
,
Genentech
,
Twitter
,
Drug Administration
,
Bayer Animal Health
,
Exchange Commission
,
Pfizer
,
Pfizer Inc
,
European Union
,
European Medicines Agency
,
Facebook
,
Roche Group
,
Emergency Use Authorization
,
Chief Executive Officer
,
Marketing Authorization Holder
,
Emergency Use
,
Drug Administrations
,
Prescribing Information
,
Caregivers Fact
,
Breakthroughs That Change Patient
,
Pfizer News
,
Annual Report
,
Looking Information
,
Factors That May Affect Future
,
New Technologies
,
Private Securities Litigation Reform Act
,
Year Ended December
,
State Level Data
,
American Academy
,
Updated January
,
Disease Control
,
Biontech
,
Nitiate
,
Rolling
,
Submission
,
Emergency
,
Authorization
,
Their
,
Covid
,
Vaccine
,
Children
,
Months
,
Through
,
Tears
,
Following
,
Request
,
Rom
,
vimarsana.com © 2020. All Rights Reserved.